Clinical Trials List
2018-04-02 - 2025-07-04
Phase II
Terminated2
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Yan-Shen Shan Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Kwang-Yu Chang Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
143 participants
